ment revealed cells in the anterior chamber and a neurotrophic corneal ulcer with corneal perforation. Considering the high suspicion of intraocular invasion of CSCC, the left eye was enucleated. Histopathologic findings showed scarring of the ciliary body with fibrosis temporally. Nasally, the sclera showed a lobular infiltration of well-differentiated squamous carcinoma. The central cornea exhibited a large ulcer with perforation and infiltrating squamous cells adhering to the posterior surface. To our knowledge, this is the first documented case of an intraocular diffuse recurrence of CSCC after resection and adjuvant brachytherapy, with clinicopathologic correlation of radiation effects on the ocular tissues. 
Introduction
Epithelial conjunctival tumors are named today as ocular surface squamous neoplasia (OSSN). They are considered "in situ" when restricted within the epithelium and "invasive" when infiltrating beyond the confines of the basal membrane as in conjunctival squamous cell carcinoma (CSCC). Invasive CSCC has a low frequency as most of the epithelial lesions are confined to the epithelium [1, 2] .
In the United States, the estimated incidence of OSSN is 8.4 cases per million. This low-grade malignancy most commonly presents as a slow-growing exophytic mass in the interpalpebral fissure, frequently involving the limbus and is often superficially invasive. It has a relatively benign clinical course and successful outcomes are achieved with excisional biopsy with or without adjunctive therapy. Neglected cases (misdiagnosis or loss to follow-up) or cases associated with immunodeficiency have been linked to more rapid growth and greater tendency to recur, in addition to ocular and orbital invasion. Metastases are extremely infrequent. Intraocular invasion is rare after primary treatment and may be prevented by adjuvant brachytherapy after resection [1, 3] .
Case Report
Our patient is a 70-year-old male, presenting to the clinic with a 1-year history of a slow-growing conjunctival mass. Ocular examination was unremarkable (pseudophakic in both eyes) with the exception of an interpalpebral lesion affecting the temporal bulbar conjunctiva of the left eye ( Fig. 1 a) . The lesion was vascularized, nonpigmented and exophytic/papillary in nature. Ultrasound biomicroscopy showed no intraocular invasion, and a size of 17 × 15 × 3.4 mm. Considering the high suspicion of invasive squamous conjunctival carcinoma, the patient underwent an excisional biopsy, with a plan for posterior adjuvant therapy. Head and neck computed tomography scan showed no locoregional extension to the lymph nodes. Pathologic study revealed a well-differentiated squamous cell carcinoma with infiltrating lobules, nest and cords with positive deep and lateral margins ( Fig. 1 b) . The patient refused topical adjuvant treatment with mitomycin C drops due to his social conditions (living alone in a rural setting, unable to keep the adequate administration of drops). One month later, brachytherapy with Ru 106 (20-mm diameter plaque) was used to treat the local intrascleral spread and to prevent recurrences and/or further invasion. Six weeks later, the patient presented with signs of anterior uveitis and corneal edema, which were diagnosed as inflammatory radiation side effects, and treated with topical steroids and antibiotics. Despite the treatment, the anterior chamber reaction increased, showing more cells and a new hypopyon. A neurotrophic corneal ulcer also appeared, with a perforation occluded by the anterior chamber content, findings that were interpreted as pseudouveitis/pseudohypopyon due to intraocular recurrence of carcinoma and neurotrophic ulcer with corneal perforation oc- cluded by carcinoma cells ( Fig. 1 c) . Magnetic resonance imaging showed an intraocular mass involving the nasal region without any signs of orbital involvement ( Fig. 1 d) . No conjunctival recurrence was noted. Oncologic examination was negative for regional or systemic extension. The CSCC was suspected to have invaded intraocularly and caused a corneal perforation. Therefore, the left eye was enucleated. Histopathologic findings showed temporal scarring of the ciliary body with fibrosis, atrophy, and disorganization of the ciliary epithelium involving the peripheral choroid. These changes were consistent with the side effects of radiation therapy. Nasally, the conjunctiva showed no signs of local recurrence. However, the sclera displayed scarring and melting with a lobular infiltration of well-differentiated squamous cell carcinoma, originating from the supraciliar space and reaching the limbus, angle, and cornea ( Fig. 2 a, b) . The central cornea exhibited a large ulcer with perforation without inflammation and additional infiltrating lobules of squamous cell carcinoma adhering to the posterior area ( Fig. 2 c, d ). The final diagnosis was intraocular infiltrative recurrence of CSCC (without conjunctival recurrence) after resection and adjuvant brachytherapy.
Discussion
A review of the 360 cases of conjunctival tumors diagnosed at the Ocular Oncology Unit of the Valladolid University Hospital revealed that 124 (39.6%) were of epithelial origin and only 11 were malignant CSCC [4] . This is the first case of recurrence and intraocular invasion treated with enucleation of the eye. The management of CSCC in ocular oncology includes incisional/excisional biopsy with margins and adjuvant therapies with antimetabolites, such as mitomycin C or interferon drops, used postoperatively in order to treat the residual tumor or margins and to prevent local recurrences. When scleral invasion is suspected, brachytherapy is the next step in treatment. In the present case, our patient refused the topical treatment and only brachytherapy was opted for. Intraocular invasion is rare and has been reported in 2-8% of cases [1, 5] . It may arise along drainage routes or nerves, in addition to tracts created by previous trauma or intraocular surgery. In our case, the corneal incision for cataract extraction incision may have been the tract for intraocular invasion. Signs suggestive of intraocular invasion include scleritis, anterior synechiae, anterior chamber cells/pseudouveitis, contiguous intraocular mass, or spontaneous perforation of the globe. Careful clinical examination and ultrasound biomicroscopy are very useful for detecting early intraocular invasion [6, 7] .
Brachytherapy and other forms of external radiation have been used for many years in the treatment of OSSN. Complications include radiation conjunctivitis, dry eye, cataract, scarring, symblepharon, ulceration, and corneal perforation [5, 8] . However, no clinicopathologic reports of the tissue effects of radiation were found in the literature. Histopathologic effects of brachytherapy and proton beam irradiation in uveal melanomas have been previously reported. These include necrosis, fibrosis, and blood vessel damage [9] . Conversely, no studies have reported these effects in anterior structures of the eye for OSSN. Our finding of a complete radiation-induced fibrous scar anteriorly is the first of its kind in the literature. In addition, a neurotrophic corneal ulcer developed secondary to radiation treatment and eventually perforated, presenting with similar histopathologic characteristics as in any type of radiation [10] .
In the present case, the extensive scarring in the temporal area demonstrated the efficacy of the treatment. The neurotrophic corneal ulcer and perforation can be attributed to limbal insufficiency caused by a combination of surgery and radiation treatment. The intraocular diffuse recurrence suggests that a subclinical infiltration of carcinoma cells through the suprachoroidal space was already present at the time of the adjuvant treatment. These cells possibly escaped the adjuvant brachytherapy, extending up to the anterior chamber, masquerading as a pseudouveitis and invading the sclera from inside the globe up to its surface. The most likely route of early intraocular invasion was the surgical wound from previous cataract surgery.
In patients presenting with CSCC with a history of previous trauma or intraocular surgery, careful clinical examination should be performed for early identification of intraocular invasion. To our knowledge, this is the first documented case of intraocular diffuse recurrence of CSCC after resection and adjuvant brachytherapy, without conjunctival relapse and with clinicopathologic correlation of radiation effects on the ocular tissues.
